Special Issue "Biomolecular Structure and Drug Design. Advances in Therapy against Neglected Infectious Diseases"
Deadline for manuscript submissions: closed (30 September 2020).
Special Issues and Collections in MDPI journals
Neglected infectious diseases (NIDs) exhibit chronic, disfiguring, and stigmatizing impacts. Such effects also threaten the achievement of the Millennium Development Goals (MDGs) and Sustainable Development Goals (SDGs). Individuals are often infected with multiple NIDs simultaneously. They represent one-sixth of the world’s population. In fact, more than a billion people are infected with one or more NIDs, causing 180,000 deaths each year, and an additional two billion are at risk. Several innovative approaches may allow for the future availability of safe and effective treatments for the most prevalent NIDs.
At the same time, recent advances in drug design are making the prediction and elucidation of biomolecular targets possible, as well as their interactions with other molecules and their mechanisms of action. Topics including bio- and chemo-informatics, small-molecule and peptide drugs and modulators, machine-learning, and peptidomimetic compounds applied to drug discovery and chemical biology are forthcoming, and may help improve on the knowledge and development of new treatments.
This Special Issue will cover the current advances in small-molecule and biologic therapy against NIDs, biomolecular structure and drug design, and all of the relevant aspects for the development and expansion of novel chemical and biomolecular NID treatments. This Special Issue will include review articles and original research articles in this field.
Dr. Alfonso T. Garcia-Sosa
Dr. Paul Nguewa
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Biomolecular structure and drug design
- Drug discovery
- Neglected diseases
- Structure prediction
- Small-molecule and peptide drugs
- Peptidomimetic drugs
- Therapeutic targets